Skip to main content

Table 1 Distribution of methylation status by selected epidemiologic and clinical characteristics

From: Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation

Gene

Methylation status

Characteristics

Age

Gender

Smoking status

Alcohol exposure

 

Overall (%)

< 65

> 65

P†

Female

Male

P†

Smoker

Non smoker

P†

Drinker

Non drinker

P†

 

PTGDR1

Yes

120 (43.8)

50

70

 

16

104

 

97

23

 

97

23

  

No

154 (56.2)

63

91

1

31

123

0.149

111

43

0.117

112

42

0.152

 

PTGDR2

Yes

50 (18.2)

16

34

 

7

43

 

42

8

 

44

6

  

No

224 (81.8)

97

127

0.156

40

184

0.678

166

58

0.199

165

59

0.042*

 

PTGER1

Yes

70 (25.5)

30

40

 

8

62

 

55

15

 

60

10

  

No

204 (74.5)

83

121

1

39

165

0.197

153

51

0.628

149

55

0.034*

 

PTGER2

Yes

48 (17.5)

18

30

 

10

38

 

37

11

 

39

9

  

No

226 (82.5)

95

131

0.630

37

189

1

171

55

1

170

56

0.457

 

PTGER3

Yes

113 (41.2)

49

64

 

17

96

 

87

26

 

86

27

  

No

161 (58.8)

64

97

1

30

131

0.516

121

40

0.775

123

38

1

 

PTGER4

Yes

22 (8.0)

6

16

 

4

18

 

18

4

 

18

4

  

No

252 (92.0)

107

145

0.183

43

209

1

190

62

0.610

191

61

0.612

 

PTGFR

Yes

53 (19.3)

15

38

 

8

45

 

44

9

 

46

7

  

No

221 (80.7)

98

123

0.043*

39

182

0.839

164

57

0.212

163

58

0.049*

 

PTGIR

Yes

56 (20.4)

20

36

 

8

48

 

46

10

 

48

8

  

No

218 (79.6)

93

125

0.366

39

179

0.691

162

56

0.293

161

57

0.078

 

TBXA2R

Yes

31 (11.3)

10

21

 

4

27

 

27

4

 

27

4

  

No

243 (88.7)

103

140

0.355

43

200

0.620

181

62

0.179

182

61

0.346

 

Gene

Tumor size

Lympho-node status

Stage

HPV status

Recurrence events

T1–2

T3–4

P†

N0

N+

P†

I, II

III, IV

P†

Negative

Positive

P†

Negative

Positive

P†

PTGDR1

54

66

 

47

73

 

24

36

 

105

15

 

47

68

 

80

74

0.274

61

93

1

96

118

0.557

95

36

0.004*

127

32

< 0.001*

PTGDR2

23

27

 

16

34

 

9

51

 

44

6

 

22

27

 

111

113

0.755

92

132

0.265

41

173

0.572

156

45

0.118

152

73

0.005*

PTGER1

30

40

 

27

43

 

15

45

 

59

11

 

29

40

 

104

100

0.269

81

123

0.888

55

159

1

141

40

0.297

145

60

< 0.001*

PTGER2

21

27

 

19

29

 

10

50

 

42

6

 

19

28

 

113

113

0.525

89

137

1

38

176

1

158

45

0.164

155

72

< 0.001*

PTGER3

52

61

 

43

70

 

23

37

 

99

14

 

38

72

 

82

79

0.462

65

96

0.708

90

124

0.658

101

37

0.005*

136

28

< 0.001*

PTGER4

11

11

 

12

10

 

6

54

 

20

2

 

9

13

 

123

129

1

96

156

0.172

16

198

1

180

49

0.266

165

87

0.035*

PTGFR

26

27

 

19

34

 

12

48

 

46

7

 

22

31

 

108

113

1

89

132

0.639

41

173

1

154

44

0.180

152

69

< 0.001*

PTGIR

28

28

 

16

40

 

9

51

 

48

8

 

24

32

 

106

112

1

92

126

0.067

47

167

0.280

152

43

0.259

150

68

< 0.001*

TBXA2R

10

21

 

13

18

 

7

53

 

27

4

 

16

15

 

124

119

0.057

95

148

1

24

190

1

173

47

0.346

158

85

1

  1. * P < 0.05, †Chi squared test